Tapestry, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Tapestry, Inc. trades at $140.62 (market cap $28.51B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Tapestry, Inc. pays a 1.13% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Tapestry, Inc. nearer its low. Which is the better fit depends on your goals.
| TPR | XBI | |
|---|---|---|
Market Cap | $28.51B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $160.49 | $164.28 |
52-Week Low | $95.69 | $85.16 |
Enterprise Value | $31.37B | — |
Dividend Yield | 1.13% | — |
Trailing returns across standard periods
Latest headlines on both assets
Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →